Albireo Pharma Liabilities 2024

Albireo Pharma Aktienanalyse

What does Albireo Pharma do?

Albireo Pharma Inc. is an American biopharmaceutical company specializing in the development and commercialization of innovative therapeutics for rare gastrointestinal and liver diseases. The company was founded in 2008 and is headquartered in Boston, Massachusetts. Albireo Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Albireo Pharma's Liabilities

Albireo Pharma's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Albireo Pharma's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Albireo Pharma's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Albireo Pharma's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Albireo Pharma’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Albireo Pharma stock

What is the level of liabilities of Albireo Pharma this year?

Albireo Pharma has a debt balance of 126.44 M USD this year.

What were the liabilities of Albireo Pharma compared to the previous year?

The liabilities of Albireo Pharma have increased by 0% dropped compared to the previous year.

What are the consequences of high debt for investors of Albireo Pharma?

High liabilities can pose a risk for investors of Albireo Pharma, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Albireo Pharma?

Low liabilities mean that Albireo Pharma has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Albireo Pharma affect the company?

An increase in liabilities of Albireo Pharma can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Albireo Pharma affect the company?

A decrease in the liabilities of Albireo Pharma can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Albireo Pharma?

Some factors that can influence the liabilities of Albireo Pharma include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Albireo Pharma so important for investors?

The liabilities of Albireo Pharma are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Albireo Pharma take to modify the liabilities?

To change its liabilities, Albireo Pharma can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Albireo Pharma pay?

Over the past 12 months, Albireo Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Albireo Pharma is expected to pay a dividend of 0 USD.

What is the dividend yield of Albireo Pharma?

The current dividend yield of Albireo Pharma is .

When does Albireo Pharma pay dividends?

Albireo Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Albireo Pharma?

Albireo Pharma paid dividends every year for the past 0 years.

What is the dividend of Albireo Pharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Albireo Pharma located?

Albireo Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Albireo Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Albireo Pharma from 8/24/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/24/2024.

When did Albireo Pharma pay the last dividend?

The last dividend was paid out on 8/24/2024.

What was the dividend of Albireo Pharma in the year 2023?

In the year 2023, Albireo Pharma distributed 0 USD as dividends.

In which currency does Albireo Pharma pay out the dividend?

The dividends of Albireo Pharma are distributed in USD.